References
- Eggesbo M, Botten G, Halvorsen R, Magnus P. The prevalence of allergy to egg: a population-based study in young children. Allergy 2001. 56: 403-411. https://doi.org/10.1034/j.1398-9995.2001.056005403.x
- Fintelmann V. Modern phytotherapy and its uses in gastrointestinal conditions. Planta Med. 1991. 57: S48-S52. https://doi.org/10.1055/s-2006-960229
- Flower RJ. The development of COX2 inhibitors. Nat Rev Drug Discov. 2003. 2: 179-191. https://doi.org/10.1038/nrd1034
- Fukai T, Satoh K, Nomura T, Sakagami H. Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra. Fitoterapia 2003. 74: 624-629. https://doi.org/10.1016/S0367-326X(03)00164-3
- Green SJ, Meltzer MS, Hibbs JB Jr, Nacy CA. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol. 1990. 144: 278-283.
- Grzanna R, Lindmark L, Frondoza CG. Ginger--an herbal medicinal product with broad anti-inflammatory actions. J Med Food 2005. 8: 125-132. https://doi.org/10.1089/jmf.2005.8.125
- Haggag EG, Abou-Moustafa MA, Boucher W, Theoharides TC. The effect of a herbal water-extract on histamine release from mast cells and on allergic asthma. J Herb Pharmacother 2003. 3: 41-54. https://doi.org/10.1080/J157v03n04_03
- Hanafy KA, Krumenacker JS, Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit. 2001. 7: 801-819.
- Kakegawa H, Matsumoto H, Satoh T. Inhibitory effects of some natural products on the activation of hyaluronidase and their anti-allergic actions. Chem Pharm Bull (Tokyo). 1992. 40: 1439-1442. https://doi.org/10.1248/cpb.40.1439
- Kamei J, Saitoh A, Asano T, Nakamura R, Ichiki H, Iiduka A, Kubo M. Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of Glycyrrhizae radix (licorice), a main component of the Kampo preparation Bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol. 2005. 507: 163-168. https://doi.org/10.1016/j.ejphar.2004.11.042
- Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, Aggarwal A, Aggarwal BB. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol. 2007. 7: 344-351. https://doi.org/10.1016/j.coph.2007.03.002
- Kim JY, Park SJ, Yun KJ, Cho YW, Park HJ, Lee KT. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur J Pharmacol. 2008. 584: 175-184. https://doi.org/10.1016/j.ejphar.2008.01.032
- Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG. Nitric oxide synthase 2 (Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis. 2001. 184: 330-336. https://doi.org/10.1086/322037
- Mine Y, Yang M. Recent advances in the understanding of egg allergens: basic, industrial, and clinical perspectives. J Agric Food Chem. 2008. 56: 4874-4900. https://doi.org/10.1021/jf8001153
- Moncada S. Nitric oxide: discovery and impact on clinical medicine. J R Soc Med. 1999. 92: 164-169.
- Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999. 18: 6853-6866. https://doi.org/10.1038/sj.onc.1203239
- Palmer RM, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun. 1993. 193: 398-405. https://doi.org/10.1006/bbrc.1993.1637
- Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003. 3: 768-780. https://doi.org/10.1038/nrc1189
- Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 2001. 480: 243-268.
- Tawata M, Aida K, Noguchi T, Ozaki Y, Kume S, Sasaki H, Chin M, Onaya T. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol. 1992. 212: 87-92. https://doi.org/10.1016/0014-2999(92)90076-G
- Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002. 53: 35-57. https://doi.org/10.1146/annurev.med.53.082901.103952
- Vallance P. Nitric oxide: therapeutic opportunities. Fundam Clin Pharmacol. 2003. 17: 1-10. https://doi.org/10.1046/j.1472-8206.2003.00124.x
- Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998. 38: 97-120. https://doi.org/10.1146/annurev.pharmtox.38.1.97
- Wang J, Sampson HA. Food allergy: recent advances in pathophysiology and treatment. Allergy Asthma Immunol Res. 2009. 1: 19-29. https://doi.org/10.4168/aair.2009.1.1.19
- Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998. 11: 355-361. https://doi.org/10.1111/j.1600-0749.1998.tb00494.x
- Yu SM, Kuo SC. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta. Br J Pharmacol. 1995. 114: 1587-1594. https://doi.org/10.1111/j.1476-5381.1995.tb14943.x
- Zhou S, Koh HL, Gao Y, Gong ZY, Lee EJ. Herbal bioactivation: the good, the bad and the ugly. Life Sci. 2004. 74: 935-968. https://doi.org/10.1016/j.lfs.2003.09.035